Dr. Mariana-Felicia Sandor, first author of the SHIELD study: Reoperation Rate in Breast-Conserving Surgery using Confocal Histolog® Scanner for Intraoperative Tissue Assessment, performs real-time, high-resolution tissue assessments during breast-conserving surgery (BCS) using the FDA-cleared Histolog Scanner. SHIELD study data indicates the innovative imaging device reduced reoperation rates during BCS from 30% to 10%, representing a 67% reduction
SamanTree Medical Highlights Research Showing 67% Reduction in Reoperation Rates for Breast-Conserving Surgery at the 2024 SABCS
"These outstanding results underscore the potential of the Histolog Scanner to enhance oncologic surgical outcomes significantly," said Olivier Delporte, CEO of SamanTree Medical. "By enabling real-time, high-resolution tissue microstructure assessments during BCS, our technology addresses a critical unmet need, reducing reoperation rates and improving patient outcomes.